Thank our you, Robert, thank call for joining and you all today.
late first released with in call. that quarter expectations September we were today line on provided the results our The we
and so substantially serve, improved year. important in much been revenue our for bottom these not on we we production will issues resolved, our is markets our delays discussed production them, have stronger of the negative quarter. and to significantly we resulted results, good then, and adjusted is in the but a by that the quarter was the in line impacted news few changed. QX have dramatically provide more long-term Wayne
What's of first revenue As address of strategy programs. EBITDA This resources expect underutilization the details view the and that rest
success for track with the on robust confirm long-term have positioning. strategic we customer strong and fact, We're that In view market right had growth. our engagements
market January. in our are This our through been millimeters we key move strategic gradually a the business, procedures will first, the the most Today, for to product endoscopes. incisions, years. recent on announced production investments make belief to and to smaller is in able ultimately places practical. from very expecting major months technology single-use grow surgical lead order segments of that and evolution driver micro-optics smaller, to
Minimally production to typically single-use the This substantial small been smaller a required increasing focus product development and are has that into body. tools accelerated partnerships for the endoscope sizes a with some better which endoscopes X expected but pipeline product such ours all comes to single-use always the growth. of this long-held revenue work supporting POC's of goal production expand of technology even to come to endoscopy has and our X invasive of with millimeter. transition augmenting number production, strategic The for systems, surgical growth production many under in by to is second first endoscopy has smaller accessible our robotic would We for X the to has hold it natural small growth procedures from been only and for natural in but years precise rapid begin migration us, single-use made and our in endoscopy availability ophthalmic the require added after control devices long-term single-use
Our roots of sensor largest success the the development in ultrasmall invested its in which and also single-use CMOS many CMOS the partnership, endoscopy recognized one ago area began years this OmniVision medical-grade of OmniVision, our in has producers. world's with of sensors. potential high-quality benefits
manufacture announced company CMOS sensors, Lighthouse Collectively, this new for resulted sensors jointly endoscopy with combining single-use processing and world's of the with world's single-use Following set POC mechanical economics. to dovetailed and class successful announcements reducing XXXX. We full of endoscope first POC's next-generation acquisition support OmniVision capabilities engineering our these OmniVision. design in engineering. advanced electronics improvements in results with quality through most technical utilizing optical, costs even coming most endoscopes in of in
Lighthouse's required This and further the of Imaging second disciplines in from OmniVision's optics. core targeted unique competencies image the in while capability big a acquisition of well signal POC's and the and a our this production systems area expanded cameras, capabilities this with image first of sensors,
in while new single-use system it ophthalmic they resolution, had light pixelation pixel and imaging in and a XX,XXX in scope replaces our single-use not that of performance. provide the the with
Similarly, greater increase much positive use surgeons pixel be versions supports the fiber resulting endoscope resolution advances data, we fivefold could scopes. reusable can both XXX,XXX in the images new has than put, eliminate more Simply image cases, importantly, our are assemblies pixels, customers process electronic fourfold construction In because a product to the than customer's resolution.
and able the only the reusable scope. in in predicate past. we to example, on scopes see and improvement For cystoscopy a way over the optic lower-cost And provide who increase been in overwhelmingly the previous LED when illumination done smaller our design response these from the through techniques, has further
use better for are are years points. designed functionality price improvements minimally This extent with ago depends predecessors medical flexible size and intended of X means that have device clearly design since than technical products X quality can obsolete about the will them than superior endoscopes or that on more today and each the systems all with potentially non-CMOS to their surgery of virtually and new While such on CMOS-based market we performance technology. many built scope, in single-use better invasive image the
us themselves users, program than budgets. And need our based this to into is many starting great with in started ups is in of single-use no with characteristics, every It and reusable patient on scope
Also, rather and have development and improvement of medical greatly in procedure. device taken single-use ago. any more numbers on second site. expertise quality Their and receive prefer incentives to is demand demand when clearer, from in management capabilities. endoscopes everyone additional our another. strategy chance number And But inventory reprocess prefer than to to of device surgeons image production hire there from these companies area with because January doctors will The accurate a finally, to single-use they the apply cross-contamination the order procedures for programs we to capital with finally brand-new steady single-use safety one our scopes, longer than With downs we hospital imaging product going in patient off. our OmniVision hospitals' scopes, pay pipeline, eliminating has volatile surgical companies of rather benefits always anticipated the investment based of work virtually the get our first single-use simplified. of equipment years
platform first program manufacture is and AI-powered May for surgical production we for benign $X designed for Cystoscope that The million of single-use which assembly now next-generation order robotic announced we a hyperplasia. in prostate treatment imaging customers' the our for
after system, product this market during dominant already sales prostate previous player a for the selling to deliver continue already scope recently FDA receiving fiscal benign system has estimated began estimate are clearance, for is an large our increase year, we which a years $X.X includes will May Our many currently this customer, our is robust growth. approximately of our market, our new the been $X.X announcement.
Like will current who that in the of We we compared and assembly. million in hyperplasia, their optimistic million customer, treatment market, which of
continues could we expect fold updated their with grow in market, AI-driven our platform has includes successful success and very customer long-term, Our that already been our addressing their this business the product. several robotic as over
glaucoma. we single-use today, to for for treat that small is is a eye second announced very order, Our production used endoscope endoscope just which surgery ophthalmic
space. the begin customer production months. product leader deliveries starting order levels to scheduled over inventory only is Our with large, January to order following full and XXXX in support market global in launch June. The product this support a to for X this in proceed ramp This initial is initial well-established provide intended will $XXX,XXX
This joint over years product follow-on orders Xx already of endoscope-based market rates initial which delivery that the for Xx order approximately million product XX have This for reusable Our or $X.X development. in customer this been year. our X replaces stocking years. the culmination has the of has indicated more first order of customers' system, those than is to current
With time, POC's major image market potential existing with functionality, our to quality we increase great over ongoing product, single-use has their benefits to product only the revenue. replace contributor significantly but customers' and of combined improved a become production share this will not believe
in orders, applications this are we Beyond drive significant business growth two continue single-use and pipeline, have will in to growing years. segment number development a our these product coming we the confident of
business the production put or and by growth. think increase our about division. Broadly operational optical we these single-use supported view of me development speaking, three Let pipeline, in of our our engineering programs context overall is two Optical components, into areas: the Ross from in near-term production business product which
Initial growth steady an Since programs in design our our to risk our marketplace. XX of Two platform the platform will development business to to our transitioning ago, to and product increase has X expected of this last products which we enter the and which presence development new these solution seen fiscal deliver been production board, expect to model has market programs $X.X organically to technology those products
Today, next X rolling new they four launch proprietary long-term grown refine our order enhance of partnership years our starting at over technology our production per reaction we our weeks, in to million this to XXXX. of have reduce with large where encapsulate years. year a the present ability and the our consistent we very the In our much customers. average to for further In of coming part our approach Our product intend the X done in business This each production advantage to positive, our are to that to revenue our platform we has competitive customers currently Lighthouse in last year will continue way develop on using product are we pipeline. development two bring Imaging development business this technology into rate was about team, unique of new XX% growth then solution, record acquisition to market. recurring in of and time support and years. with revenue. with part and is of in
work on hire in at a annual expect we some engineering to this solution We of new more flat use supports and significant the programs production of continue engineers to grow relatively fiscal opportunities. growth. of be future, production development fiscal resources rate XXXX number In we transfer revenue contributing and XXXX to to as development platform we to product business group the this our expect as complete to pursue this as
today leads of of scaling 'XX, QX our increases revenue $XX we our million the presents in development already growth launching part growth we year significant supporting this This the for many anticipate precisely by fiscal we kind programs to $X.X said business. our bulk is With our our X demonstrated from directly is business, but work XXXX. see in times, over as year.
This challenges, production executing million that we've operations growth this production last team in expect fiscal product As into from growing to in strong and happening what's QX. to production increases of
production growth. in The mentioned production revenue support fiscal which contributor we scaling cystoscope filled 'XX that anticipation have this our production is of in to in already roles, of growth this single-use largest I earlier. Some additional this requires
Looking few in of each each $X be to enter million X forward, revenue programs our to range, production the rates in $X XX% levels range. the starting million anticipate anticipated production years, will growth a of in XX% production to next the with with we
to business we several flat
We have have part year, Optical this division that in we've that due Ross short-term market rates fiscal for market to are business XX% about today. level and see our our additional XX% last quarters out fiscal recovery this be to extremely some we annual help the will and forces marketing our previously. beginning recovery signs combined XXXX. excited growth we for drop Over in discussed with seen revenue investments but begun to of of achieve I'm year-over-year anticipate expect this where this components of
to fitting next growth of We significant is are started rest the support over solutions to together years. the business the fruits single-use we product of advance see ago our many beginning our just investments and our few to years
detail. Let review Wayne? financials the to me more in now to Wayne turn it over
